X4 Pharmaceuticals (XFOR) Goodwill & Intangibles (2019 - 2026)

X4 Pharmaceuticals (XFOR) has reported Goodwill & Intangibles for 8 consecutive years, with $30.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill & Intangibles rose 12.89% year-over-year to $30.5 million; the trailing twelve-month figure through Jun 2026 stood at $30.5 million (up 12.89% YoY), and the FY2025 full-year result was $26.7 million, down 2.56% from the prior year.
• Goodwill & Intangibles improved to $30.5 million in Q2 2026 per XFOR's latest filing, from $26.5 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $30.5 million in Q2 2026 and bottomed at $17.4 million in Q1 2022.
• Historically, Goodwill & Intangibles has averaged $22.4 million across 5 years, with a median of $21.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles tumbled 36.0% in 2022, then soared 59.94% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then jumped by 57.63% to $27.4 million in 2024, then fell by 2.56% to $26.7 million in 2025, then advanced by 14.26% to $30.5 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $30.5 million, $26.5 million, and $26.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.